NEW YORK, April 28, 2010 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE Amex:DXR), a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement from The University of Florida College of Veterinary Medicine in Gainesville, Florida. This will provide the Veterinary Medical Center with a Blood Volume Analyzer-100 (BVA-100), an instrument which enables semi-automated measurement of a patient's total blood volume, red blood cell volume and plasma volume. Blood volume abnormalities have been observed in human patients suffering from various medical conditions, such as heart failure or trauma. This will provide an opportunity to assess whether the BVA-100 can be used to diagnose and treat similar conditions in animal subjects.
Daxor Announces That The University Of Florida College Of Veterinary Medicine In Gainesville, FL Acquires BVA-100 Blood Volume Analyzer
Check Out Our Best Services for Investors
Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.